| created | [InstanceEdit:9665475] Orlic-Milacic, Marija, 2019-10-31 |
| dbId | 9665477 |
| displayName | Comapred with the wild type ERBB2, ERBB2 G309E, ERBB2 S310F ... |
| schemaClass | Summation |
| text | Comapred with the wild type ERBB2, ERBB2 G309E, ERBB2 S310F and ERBB2 S310Y are more sensitive to tyrosine kinase inhibitors lapatinib, neratinib and afatinib (Greulich et al. 2012). ERBB2 G309A was also responsive to lapatinib and neratinib (Bose et al. 2013). |
| (summation) |
© 2026 Reactome